Daix (France), New York City, (New York, United States), November 21, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the ...

MV purification, achieving unmatched levels of both purity and yield. Innovative Approach to MV Purification The study, titled "Highly Pure Measles Virus Generated by Combination of Salt -Active ...

28th, 2024 at 07:00 CET and host a live Q&A session at 13:00 CET. The quarterly report and a pre-recording of the third quarter presentation will be made available on ...

Grieg Seafood ASA will release its third quarter 2024 results on Wednesday, November 27, 2024, at 6:00 a.m. CET. The same day at 8:00 a.m. CET, CEO Andreas Kvame and CFO Atle Harald Sandtorv will ...

In the first quarter (July-September 2024) of the 2024-25 financial year, Amplitude Surgical sales came to €21.8 million, up 6.1% and 7.5% at constant exchange rates. Sales in France rose by 4.5%, ...

(a) For explanations and reconciliations of Adjusted EBITDA, Adjusted EBITDA ...

collaboration with Vår Energi, Aker Solutions, and Arribatec. For further information, please contact: Herman Sjøberg, CEO, Tel: +47 926 62 233, e-mail: [email protected] Olav Gram Degnes, ...

certain primary insiders received common shares in the Company. In order to cover taxes payable upon delivery of the common shares, a primary insider has sold common shares in the market as further ...

NOK 1.00 to NOK 0.25 (the "Share Capital Reduction").

that the 2024 Annual General Meeting of the Company was held on Thursday, November 21, 2024 at 1:00 pm (GMT) at Flemings Mayfair Hotel, Half Moon Suite, 7-12 Half Moon St, London W1J 7BH. The Meeting ...

a total share capital in the amount of USD 370,052,548. The new shares have been legally and validly issued and are fully paid.

will prioritize towards 2030. These focus areas lead us into several major and important changes. We are now adjusting our organization so that we are well-equipped to implement these changes and ...